---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-029392"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:18:03.688283+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Reviva awards FY2023 bonuses: CEO $157,500, CFO $95,940, VP $77,376 in options

## Summary
- FY2023 incentive bonuses for named executive officers paid as immediately vested stock options in lieu of cash.
- CEO Laxminarayan Bhat granted 158,451 options at $1.20 per share; bonus value $157,500.
- CFO Narayan Prabhu granted 96,519 options at $1.20 per share; bonus value $95,940.
- VP Seema Bhat granted 77,843 options at $1.20 per share; bonus value $77,376.

## SEC filing metadata
- accession: 0001437749-24-029392
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774924029392/0001437749-24-029392-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924029392/rvph20240917_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-029392
- JSON: https://secwatch.observer/filing/0001437749-24-029392.json
- Plain text: https://secwatch.observer/filing/0001437749-24-029392.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.